Page 103 - Clinical Development News Today

After years of shrinking revenue, new CEO Richard Francis is switching the emphasis to innovation. "Globes" looks at Teva's drug development pipeline.

Alan Fisher appointed Chair of the Board of DirectorsTim Cunningham joins as Chief Financial Officer

Roundup summary of digital health hires and executive board appointments from GHX, QuantHealth, Hopper, Icario, Carenet Health, others

Dublin, June 29, 2023 (GLOBE NEWSWIRE) -- The "Viral Vector Manufacturing: Global Strategic Business Report" report has been added to ...

Medical Director, Oncology - Early Development in Full time, Director, Biomedicine with Adveritas - F. Hoffmann la Roche. Apply Today.

The combination of galinpepimut-S and nivolumab provided positive survival outcomes with an acceptable safety profile in patients with malignant pleural mesothelioma who were refractory to or relapsed after at least 1 line of standard treatment.

Primary Endpoint of Safety and Efficacy Endpoint Both Met with Clinical Activity and Increased Survival Observed

NEW YORK, June 26, 2023 /PRNewswire/ -- Ichnos Sciences Inc., a global clinical-stage biotechnology company developing innovative multispecific an...

Lindus Health say the number of people living with type 2 diabetes in the US is ‘staggering’.

A small molecule compound has shown to induce strong anti-tumor immune responses – an area where medical need is high.